AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $405,000 | +45.2% | 8,523 | +10.4% | 0.15% | -55.8% |
Q4 2018 | $279,000 | -62.8% | 7,723 | -44.2% | 0.34% | +13.4% |
Q1 2018 | $751,000 | +0.4% | 13,844 | +10.6% | 0.30% | -18.1% |
Q4 2017 | $748,000 | +11.1% | 12,516 | -9.6% | 0.36% | -47.2% |
Q3 2017 | $673,000 | – | 13,844 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |